Harold Shlevin

Harold H.
Shlevin was the founder of Tikvah Therapeutics, Inc., founded in 2006, where the title held was President & Chief Executive Officer in 2008.
Dr. Shlevin is also the founder of Ciba Vision Ophthalmics Co...
Dr. Shlevin is currently a Director at Galectin Therapeutics, Inc. since 2020, a Director at Moonlight Therapeutics, Inc., and a Member of The Institute of Electrical & Electronics Engineers, Inc., Licensing Executives Society, American Society for Pharmacology & Experimental Therapeutic, and The American Physiological Society.
Former positions include President, CEO, Director & Global SVP at Solvay Pharmaceuticals, Inc. from 2000 to 2006; Chairman at Unimed Pharmaceuticals LLC; Independent Director at Correvio Pharma Corp.
from 2004 to 2016; Director & Global Senior Vice President at Solvay Pharmaceuticals SA in 2006; Director at Solvay Draka, Inc.; Director at NeurOp, Inc.; VP, Head-Operations & Commercial Development at Altea Therapeutics Corp.
from 2008 to 2009; Manager & Startup Catalyst at Advanced Technology Development Center from 2009 to 2012; and Assistant Professor at Mayo Clinic College of Medicine & Science.
Education includes undergraduate studies at Boston University and graduate and doctorate degrees from the University of Rochester Medical Center.